假性痛风、软骨钙化、CPPD等:术语如水晶般清晰还是如泥般模糊?是时候重新考虑焦磷酸钙沉积的命名了
本文是一篇观点文章,指出焦磷酸钙沉积(CPPD)在诊断、分类标准、标准化诊断方法和循证治疗方面存在挑战,导致其常被视作痛风的「穷亲戚」。近年来美国风湿病学会/欧洲抗风湿病联盟分类标准、影像学推荐、OMERACT超声定义及核心域集等进展推动了该领域发展,但CPPD命名术语不一致仍阻碍研究与临床实践。文章旨在探讨CPPD命名的历史演变、评估既往标准化努力的影响,并提出建立共同语言的可行路径。
要点
- CPPD命名术语在科学文献中不一致,多种术语和缩略语被用于描述该病及其表现。
- 许多「假性综合征」(如假性痛风)和纯影像学描述词(如软骨钙化)仍被临床医生和研究者互换使用。
- CPPD领域已取得美国风湿病学会/欧洲抗风湿病联盟分类标准、影像学推荐、OMERACT超声定义及核心域集等里程碑进展。
核心结论
- CPPD命名术语不一致阻碍了研究与临床实践的进步,本文旨在探讨命名历史演变、评估既往标准化努力的影响,并提出建立共同语言的可行路径。
研究设计与样本
- 本文为观点文章,通过回顾CPPD命名的历史演变、评估既往标准化努力的影响,并与其他风湿病进行类比,提出建立共同语言的可行路径。
主要发现
- CPPD诊断因临床表现多样、缺乏分类标准、缺乏标准化诊断方法、临床认识不足以及最显著的缺乏循证治疗而存在困难,常被视作痛风的「穷亲戚」。
- 近年来CPPD获得风湿病学界更多关注,里程碑包括首个美国风湿病学会/欧洲抗风湿病联盟分类标准、欧洲抗风湿病联盟影像学临床应用推荐、经验证的OMERACT超声定义和评分系统以及OMERACT CPPD核心域集。
- CPPD命名术语在科学文献中仍不一致,许多「假性综合征」(如假性痛风)和纯影像学描述词(如软骨钙化)仍被临床医生和研究者互换使用,作为疾病名称或其临床/影像学表现之一。
- 术语缺乏标准化使卫生保健专业人员、研究者之间以及医患之间的沟通复杂化,对有效诊疗和研究进展构成难以逾越的障碍。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Scientific interest in calcium pyrophosphate deposition (CPPD) has been limited by several challenges. These include difficulties in diagnosis due to diverse clinical presentations, the lack of classification criteria, the absence of standardised diagnostic modalities, underrecognition in clinical care, and, most significantly, the lack of evidence-based treatments. Consequently, CPPD was often regarded as the 'poor cousin' of gout. Fortunately, in recent years, CPPD has garnered increased attention from the rheumatology community. Milestones such as the first American College of Rheumatology/European Alliance of Association for Rheumatology classification criteria, the European Alliance of Association for Rheumatology recommendations for the use of imaging in clinical practice, validated OMERACT ultrasound definitions and scoring system, and the OMERACT core domain sets for CPPD have significantly advanced the field. Yet, unresolved issues regarding CPPD nomenclature hold back advancement in both research and clinical practice. The terminology surrounding CPPD remains inconsistent in the scientific literature, with numerous terms and acronyms used to describe the condition and its manifestations. For example, many 'pseudosyndromes' (eg, pseudogout) and purely radiographic descriptors (eg, chondrocalcinosis) are still commonly used by clinicians and researchers interchangeably, as either the name of the condition or one of its clinical or radiographic manifestations. This lack of standardisation complicates communication among health care professionals, researchers, and between doctors and patients, creating insurmountable barriers to effective care and research advances. In this viewpoint, we highlight the value of standardised terminology, drawing parallels with other rheumatic diseases. We aimed to explore the historical evolution of CPPD nomenclature, assess the impact of previous standardisation efforts, and propose a possible way for a common language.
引用
- Sirotti S, Jauffret C, Adinolfi A, et al. Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?-The time has come to reconsider the nomenclature of calcium pyrophosphate deposition. Ann Rheum Dis. 2025. PMID: 40312208. doi:10.1016/j.ard.2025.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。